Mirtazapine Transdermal Ointment
23 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
23
Total Reports
10
Deaths Reported
4350.0%
Death Rate
Active Ingredients
Mirtazapine Transdermal Ointment
Administration Routes
TopicalUnknownTransdermalOther
Species Affected
Cat 22
Dog 1
Most Affected Breeds
Domestic Shorthair 16
Ragdoll 2
Domestic Longhair 2
Russian 1
Siamese 1
Bulldog - French 1
Most Reported Reactions
Lethargy (see also Central nervous system depression in 'Neurological') 9
Death by euthanasia 7
Anorexia 6
Hiding 5
Vomiting 5
Behavioural disorder NOS 4
Not eating 4
Hyperglycaemia 4
Diarrhoea 4
Vocalisation 3
Other abnormal test result NOS 3
Leucocytosis NOS 3
Outcome Breakdown
Ongoing
8 (34.8%)
Euthanized
7 (30.4%)
Recovered/Normal
4 (17.4%)
Died
3 (13.0%)
Outcome Unknown
1 (4.3%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.